Elite Diagnostic Limited (JMSE:ELITE)
1.940
+0.390 (25.16%)
At close: Sep 4, 2026
| Market Cap | 685.60M +28.5% |
| Revenue (ttm) | 867.30M +1.6% |
| Net Income | 31.51M -1.6% |
| EPS | 0.09 -1.6% |
| Shares Out | 353.40M |
| PE Ratio | 21.76 |
| Forward PE | n/a |
| Dividend | 0.01 (0.56%) |
| Ex-Dividend Date | Sep 19, 2025 |
| Volume | 71,442 |
| Open | n/a |
| Previous Close | 1.550 |
| Day's Range | 1.550 - 2.000 |
| 52-Week Range | 1.020 - 2.000 |
| Beta | 0.07 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 13, 2026 |